Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Modern approaches to diagnosis and treatment of attention deficit hyperactivity disorder

Корабелникова Е. А.
Педиатрия. Журнал им. Г.Н. Сперанского
Т. 98, Вып. 5, С. 114-122
Опубликовано: 2019
Тип ресурса: Статья

DOI:10.24110/0031-403X-2019-98-5-114-122

Аннотация:
Attention deficit hyperactivity disorder (ADHD) is an urgent problem due to the high incidence rate, reaching 3–5[%] in the child population. The article discusses diagnostic criteria for ADHD and manifestation peculiarities in different age periods. It also duscusses etiopathogenesis of ADHD as a multifactorial developmental disorder; reviews main groups of drugs used for the pharmacological correction of the disease, among which nootropics, in particular aminophenylbutyric acid («Anvifen»), occupy a special place. Author discusses and justifies the need for an integrated approach to ADHD treatment, which should combine pharmacotherapy, neuropsychological correction and psychotherapy with a child, parents and teachers. © 2019, Pediatria Ltd. All rights reserved.
Ключевые слова:
Anvifen; Attention deficit hyperactivity disorder; Complex treatment; Diagnostic criteria; Etiopathogenesis; Nootropics; Pharmacotherapy; Psychocorrection
aminophenylbutyric acid; nootropic agent; unclassified drug; Article; attention deficit disorder; child; developmental disorder; drug therapy; human; morbidity; neuropsychology; psychotherapy
Язык текста: Русский
ISSN: 1990-2182
Корабелникова Е. А.
Korabelnikova E. A.
Modern approaches to diagnosis and treatment of attention deficit hyperactivity disorder
Текст визуальный непосредственный
Педиатрия. Журнал им. Г.Н. Сперанского
ООО "Педиатрия"
Т. 98, Вып. 5 С. 114-122
2019
Статья
Anvifen Attention deficit hyperactivity disorder Complex treatment Diagnostic criteria Etiopathogenesis Nootropics Pharmacotherapy Psychocorrection
aminophenylbutyric acid nootropic agent unclassified drug Article attention deficit disorder child developmental disorder drug therapy human morbidity neuropsychology psychotherapy
Attention deficit hyperactivity disorder (ADHD) is an urgent problem due to the high incidence rate, reaching 3–5[%] in the child population. The article discusses diagnostic criteria for ADHD and manifestation peculiarities in different age periods. It also duscusses etiopathogenesis of ADHD as a multifactorial developmental disorder; reviews main groups of drugs used for the pharmacological correction of the disease, among which nootropics, in particular aminophenylbutyric acid («Anvifen»), occupy a special place. Author discusses and justifies the need for an integrated approach to ADHD treatment, which should combine pharmacotherapy, neuropsychological correction and psychotherapy with a child, parents and teachers. © 2019, Pediatria Ltd. All rights reserved.